Toxicology data is vital for the approval of an NDA because it directly impacts patient safety. The FDA relies on this information to make informed decisions about whether a drug should be approved for public use. Without comprehensive toxicological data, the risks associated with a new drug might not be fully understood, potentially leading to adverse health outcomes. Thus, toxicology provides the foundation for determining the safety margin of the drug.
